Drug class/name |
|
Anti-infectives, n (%)
|
735 (43.1)
|
Beta-lactams, n (%)
|
348 (20.4)
|
Sulphonamides, n (%)
|
81 (4.7)
|
Tetracyclines, n (%)
|
70 (4.1)
|
Quinolones, n (%)
|
64 (3.8)
|
Macrolides, n (%)
|
50 (2.9)
|
Anti-mycobacterials, n (%)
|
31 (1.8)
|
Anti-protozoals, n (%)
|
22 (1.3)
|
Aminoglycosides, n (%)
|
21 (1.2)
|
Anti-virals, n (%)
|
14 (0.8)
|
Glycopeptides, n (%)
|
12 (0.7)
|
Anti-fungals, n (%)
|
8 (0.5)
|
Lincosamides, n (%)
|
7 (0.4)
|
Other anti-infectives, n (%)
|
7 (0.4)
|
Nervous System, n (%)
|
390 (22.9)
|
Musculoskeletal System, n (%)
|
348 (20.4)
|
Cardiovascular system, n (%)
|
55 (3.2)
|
Gastrointestinal System, n (%)
|
39 (2.3)
|
Respiratory System, n (%)
|
33 (1.9)
|
Anaesthesia, n (%)
|
24 (1.4)
|
Immune System and Malignant Diseases, n (%)
|
16 (0.9)
|
Ear, Nose and Throat, n (%)
|
8 (0.5)
|
Eye, n (%)
|
7 (0.4)
|
Skin, n (%)
|
5 (0.3)
|
Blood and Nutrition, n (%)
|
5 (0.3)
|
Genito-urinary system, n (%)
|
4 (0.2)
|
Vaccines, n (%)
|
2 (0.1)
|
Endocrine System, n (%)
|
2 (0.1)
|
Unknown Aetiology, n (%)
|
33 (1.9)
|